Thomas Templeman - 31 Mar 2023 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
Chief Technology Officer
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
31 Mar 2023
Net transactions value
-$16,002
Form type
4
Filing time
04 Apr 2023, 17:04:29 UTC
Previous filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Tax liability $16,002 -4,103 -2.1% $3.90 188,244 31 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.

Remarks:

Exhibit 24 - Power of Attorney